Ground-breaking Research Unveils Cost-Effective Model to Boost COVID-19 Immunisation in Developing Countries

The study, conducted in Sierra Leone in 2022, comes at a critical time as developing countries grapple with the aftermath of the economic and health shocks induced by COVID-19. By December 2022, Sierra Leone had achieved the World Health Organisation's global target, immunising 70% of its adult population against COVID-19. This cost-effective model has the potential for replication across developing countries with large rural populations and similar transport, community, and infrastructure setups. This initiative, jointly decided between the Ministry of Health and the researchers, will include the COVID-19 vaccine, HPV vaccine for girls aged 10-12, and routine immunisations for children aged 0-6. In conclusion, this research marks a pivotal moment in the fight against infectious diseases in developing countries.